← Back to Patent Explorer
US4325957A Expired / Lapsed US ⏱️ 0.0 years remaining

2-Acylaminomethyl-1,4-benzodiazepine derivatives and their salts and pharmaceutical compositions thereof

Assignee: AbbVie Pharmaceuticals GmbH
•
Filing: 1980-12-23
•
Granted: 1982-04-20
•
Expires: 2000-12-23
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract Novel 2-acylaminomethyl-1H-2,3-dihydro-1,4-benzodiazepine derivatives are disclosed which possess the Formula I <IMAGE> (I) wherein R1 represents hydrogen, lower akyl, lower alkenyl or cyclopropylmethyl; R2 represents hydrogen, lower alkyl or lower alkenyl; R3 represents a group of the formula a, b, c or d; <IMAGE> +TR <IMAGE> wherein R is hydrogen or C1-C3- alkyl; R4 is hydrogen, lower alkyl, lower alkoxy, nitro or halogen, and R4' is hydrogen or C1-C4- alkyl and the aromatic groups A and B may be unsubstituted or substituted by 1 to 3 substituents such as halogen, lower alkylthio, lower alkoxy, lower alkyl, hydroxy, nitro, trifluoromethyl or methylenedioxy or ethylenedioxy and optical isomers and acid addition salts of the compounds. In addition to psycho pharmacological, diuretic and antiarrhythmic properties, the novel compounds of Formula I possess primarily outstanding analgesic activities and are low in toxicity. The compounds are prepared by acylating 2-aminomethyl-1,4-benzodiazepine derivatives with corresponding carbonic acid derivatives. Furthermore, 2-azidomethyl-1,4-benzodiazepine derivatives are disclosed which provide valuable intermediates for the preparation of the compounds of Formula I yet also possess themselves pharmacological activities.

Inventors

  • 👤 Horst Zeugner
  • 👤 Dietmar Roemer
  • 👤 Hans Liepmann
  • 👤 Wolfgang Milkowski

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-31 22:19
CPC Classifications
C; C07; C07D; C07D401/00; C07D401/02; C07D401/12; A; A61; A61K; A61K31/00; A61K31/33; A61K31/395; A61P; A61P25/00; A61P25/04; C07D243/00; C07D243/06; C07D243/10; C07D243/14; C07D243/16; C07D245/00; C07D245/04; C07D245/06; C07D407/00; C07D407/02; C07D407/12; C07D491/00; C07D491/02; C07D491/04

Claims Analysis

Total Claims: 23
Claim 1
Independent Claim 146 words
A compound selected from the group consisting of 2-acylaminomethyl-1H-2,3-dihydro-1,4-benzodiazepine derivatives of the Formula I ##STR14## wherein R 1 represents hydrogen, lower alkyl, lower alkenyl or cyclopropylmethyl, R 2 represents hydrogen, lower alkyl or lower alkenyl, R 3 represents a group of the formula a, b, c, or d ##STR15## wherein R is hydrogen or C 1 -C 3 -alkyl, R 4 is hydrogen, lower alkyl, lower alkoxy, nitro or halogen, and R 4 ' is hydrogen or C 1 -C 4 -alkyl, and the phenylene group A and the phenyl group B independently from each other each may be unsubstituted or be substituted by 1 to 3 substituents selected from the group consisting of halogen, lower alkylthio, lower alkoxy, lower alkyl, hydroxy, nitro and trifluoromethyl, or be substituted at two adjacent carbon atoms by methylenedioxy or ethylenedioxy, and optical isomers and pharmaceutically-acceptable acid addition salts thereof.
Claim 2
Dependent Claim 146 words
A compound selected from the group consisting of 2-acylaminomethyl-1H-2,3-dihydro-1,4-benzodiazepine derivatives of the Formula I ##STR14## wherein R 1 represents hydrogen, lower alkyl, lower alkenyl or cyclopropylmethyl, R 2 represents hydrogen, lower alkyl or lower alkenyl, R 3 represents a group of the formula a, b, c, or d ##STR15## wherein R is hydrogen or C 1 -C 3 -alkyl, R 4 is hydrogen, lower alkyl, lower alkoxy, nitro or halogen, and R 4 ' is hydrogen or C 1 -C 4 -alkyl, and the phenylene group A and the phenyl group B independently from each other each may be unsubstituted or be substituted by 1 to 3 substituents selected from the group consisting of halogen, lower alkylthio, lower alkoxy, lower alkyl, hydroxy, nitro and trifluoromethyl, or be substituted at two adjacent carbon atoms by methylenedioxy or ethylenedioxy, and optical isomers and pharmaceutically-acceptable acid addition salts thereof.
Claim 3
Dependent Claim 24 words
The compound as defined in claim 1 wherein R 1 is methyl, R 2 is hydrogen, R 3 is a group of Formula b.
Claim 4
Dependent Claim 12 words
The compound as defined in claim 2 wherein R 3 is 2-thiophene.
Claim 5
Dependent Claim 42 words
The compound as defined in claim 3 wherein B is unsubstituted phenyl and A is unsubstituted phenylene or phenylene substituted by 7-fluoro, 7-methyl, 7-isopropyl, 6, 8-dimethyl, 7,8-dimethyl, 7-methoxy, 7-n-propyloxy, 7,8-methylenedioxy, 7,8-ethylenedioxy, 7-trifluoromethyl, 7-nitro, 7,8-dimethoxy, 6,8-dimethoxy, 8-fluoro, 8-chloro, 8-ethyl, 8-methylthio, 8-methoxy or 8-ethyloxy.
Claim 6
Dependent Claim 22 words
The compound as defined in claim 3 wherein A is unsubstituted phenylene and B is unsubstituted phenyl, 2-fluorophenyl, 3-methoxyphenyl, 2,6-dimethoxyphenyl or 3,4-dimethoxyphenyl.
Claim 7
Dependent Claim 34 words
The compound as defined in claim 3 wherein A is phenylene substituted by 7-fluoro, 7-bromo, 7-methyl, 8-methoxy or 7, 8-methylenedioxy and B is 2-fluorophenyl, 3-fluorophenyl, 4-fluorophenyl, 2-chlorophenyl, 2-bromophenyl, 2-methylphenyl, 2-trifluoromethylphenyl, 3-trifluoromethylphenyl, 4-trifluoromethylphenyl or 3,4,5-trimethoxyphenyl.
Claim 8
Dependent Claim 60 words
The compound as defined in claim 2 wherein A is unsubstituted phenylene or phenylene substituted by 7-fluoro, 8-fluoro, 7-methyl, 8-methylthio, 7-methoxy, 8-methoxy, 8-ethyloxy, 7-n-propyloxy or 7,8-methylenedioxy, and B is unsubstituted phenyl, 2-fluorophenyl, 3-fluorophenyl, 4-fluorophenyl or 3,4,5-trimethoxyphenyl, and R 3 is a group of the formula ##STR16## wherein R 4 is 5-chloro, 4-bromo, 5-bromo, 3-methyl, 4-methyl, 5-methyl, 5-ethyl, 5-methoxy or 5-ethyloxy.
Claim 9
Dependent Claim 35 words
The compound as defined in claim 2 wherein R 3 is 3-thiophene, B is unsubstituted phenyl and A is phenylene substituted by 7-methyl, 8-methyl, 9-methyl, 8-ethyl, 7-n-propoxy, 7-isopropyl, 7-methoxy, 8-methoxy, 8-ethoxy, 8-methylthio, 6,8-dimethyl or 7,8-dimethyl.
Claim 10
Dependent Claim 62 words
The compound as defined in claim 2 wherein R 3 is a group of the formula ##STR17## wherein R 4 is hydrogen or 2-methyl, A is unsubstituted phenylene or phenylene substituted by 7-fluoro, 7-bromo, 7-chloro-8-methoxy, 7-fluoro-8-methoxy, 7-methyl, 8-methyl, 9-methyl, 6-methoxy, 8-methoxy, 8-ethyloxy, 8-isopropyloxy, 8-nitro, 8-methyl-6-methoxy, 7,8-methylenedioxy, 6,7-methylenedioxy, 6-hydroxy, 7,8-dimethoxy and B is phenyl, 2-fluorophenyl, 2-chlorophenyl, 3-methoxyphenyl, 4-methoxyphenyl, 3,4-dimethoxyphenyl, 3,4,5-trimethoxyphenyl, 3-trifluoromethylphenyl or 4-trifluoromethylphenyl.
Claim 11
Dependent Claim 35 words
The compound as defined in claim 1 wherein R 1 is methyl, R 2 is hydrogen and R 3 is a group of formula a and A and B are as defined in claim 1.
Claim 12
Dependent Claim 59 words
The compound as defined in claim 10 wherein R 3 is a group of the formula ##STR18## wherein R 4 is hydrogen, 5-methyl or 5-nitro, A is unsubstituted phenylene or phenylene substituted by 7-fluoro, 7-bromo, 7-methyl, 8-ethyl, 7-isopropyl, 8-methylthio, 6,8-dimethyl, 7,8-dimethyl, 7-methoxy, 6,8-dimethoxy, 7,8-dimethoxy, 7-n-propyloxy, 8-methoxy, 7,8-methylenedioxy or 7-chloro, and B is phenyl, 2-chlorophenyl, 2-fluorophenyl, 3-methoxyphenyl, 3,4-dimethoxyphenyl, or 3,4,5-trimethoxyphenyl.
Claim 13
Dependent Claim 82 words
The compound as defined in claim 10 wherein R 3 is a group of the formula ##STR19## wherein R 4 is hydrogen, 2-methyl or 5-methyl, A is unsubstituted phenylene or phenylene substituted by 7-chloro, 8-chloro, 7-fluoro, 8-fluoro, 7-fluoro-8-methoxy, 8-nitro, 7-methyl-9-chloro, 8-methylthio, 7-methyl, 8-methyl, 8-methyl-6-methoxy, 8-ethyl, 7-isopropyl, 7,8-dimethyl, 6,8-dimethyl, 7-methoxy, 8-methoxy, 8-ethyloxy, 7-n-propyloxy, 8-isopropyloxy, 7,8-dimethoxy, 7,8-methylenedioxy, or 7,8-ethylenedioxy, and B is phenyl, 2-fluorophenyl, 3-fluorophenyl, 4-fluorophenyl, 2-bromophenyl, 2-chlorophenyl, 2-methylphenyl, 2-trifluoromethylphenyl, 3-trifluoromethylphenyl, 4-trifluoromethylphenyl, 2,6-difluorophenyl, 3-trifluoromethyl-4-chlorophenyl, 2,4-dichlorophenyl, 2-methoxyphenyl, 3-methoxyphenyl, 4-methoxyphenyl, 2,6-dimethoxyphenyl, 3,4-dimethoxyphenyl, 2,3-dichlorophenyl, 3,4,5-trimethoxyphenyl or 2,4-difluorophenyl.
Claim 14
Dependent Claim 44 words
The compound as defined in claim 1 wherein R 1 is methyl, R 2 is hydrogen, R 3 is 1H-pyrrol, 1-methylpyrrol or 1,2-dimethylpyrrol, A is unsubstituted phenylene or phenylene substituted by 8-methyl, 8-methoxy or 7,8-methylenedioxy, and B is phenyl, 2-fluorophenyl, 2-bromophenyl, 2-methylphenyl or 2-methoxyphenyl.
Claim 15
Dependent Claim 43 words
The compound as defined in claim 1 wherein R 1 is methyl, R 2 is hydrogen, R 3 CO is picolinoyl, nicotinoyl or isonicotinoyl, A is unsubstituted phenylene or phenylene substituted by 7-bromo, 7-chloro or 8-methoxy and B is phenyl, 2-fluorophenyl or 2-chlorophenyl.
Claim 16
Dependent Claim 17 words
The compound as defined in claim 1 wherein R 2 is hydrogen, methyl, ethyl, n-propyl or allyl.
Claim 17
Dependent Claim 19 words
The compound as defined in claim 1 wherein R 1 is hydrogen, methyl, ethyl, n-propyl, i-propyl, n-butyl or cyclopropylmethyl.
Claim 18
Dependent Claim 1 words
1-methyl-2-[(thiophene-3-carbonyl)-aminomethyl]-5-(2-fluorophenyl)-1H-2,3-dihydro-1,4-benzodiazepine.
Claim 19
Dependent Claim 1 words
1-methyl-2-[(thiophene-3-carbonyl)-aminomethyl]-5-(2-fluorophenyl)-1H-2,3-dihydro-1,4-benzodiazepine.
Claim 20
Dependent Claim 23 words
A pharmaceutical composition comprising an analgesically effective amount of at least one compound as defined in claim 1 and a pharmaceutically acceptable carrier.
Claim 21
Dependent Claim 21 words
A pharmaceutical composition comprising an analgesically effective amount of the compound as defined in claim 17 and a pharmaceutically acceptable carrier.
Claim 22
Dependent Claim 27 words
A method of treating pain disorders in larger mammals which comprises administering to a larger mammal an effective amount of a compound as defined in claim 1.
Claim 23
Dependent Claim 27 words
A method of treating pain disorders in larger mammals which comprises administering to a larger mammal an effective amount of a compound as defined in claim 17.

References Cited (Backward Citations)

US3738999A Cited
DE2353160A1 Cited
DE2436147A1 Cited
US3947475A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1985-04-19 1985-10-19 1986-04-20 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1989-04-19 1989-10-19 1990-04-20 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1993-04-19 1993-10-19 1994-04-20 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag